KAO JOHN E 4
4 · Alignment Healthcare, Inc. · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare (ALHC) CEO John Kao Sells 180,000 Shares
What Happened
- John E. Kao, CEO of Alignment Healthcare (ALHC), sold 180,000 shares on March 10, 2026 in an open-market disposition. The weighted-average price was $18.19 per share, generating total proceeds of $3,273,552. This was a sale (not a purchase or option exercise) executed under a pre-established trading plan.
Key Details
- Transaction date: 2026-03-10; filing date: 2026-03-10 (filed same day).
- Price: weighted-average $18.19; per-share executions ranged from $17.86 to $18.57 (reporting person can provide exact breakdown on request).
- Total shares sold: 180,000; total proceeds: $3,273,552.
- 10b5-1 plan: sale executed under a Rule 10b5-1 plan adopted March 12, 2025 (footnote F1).
- Ownership note: footnote indicates the securities are held by JEK Trust (dated Feb 8, 2021), of which Mr. Kao is trustee (footnote F3).
- Timeliness: filing appears timely (transaction and report both dated 2026-03-10).
Context
- Sales under 10b5-1 plans are pre-arranged and generally routine; they do not by themselves indicate management’s current view on the company. For more granular pricing details per execution, the filer notes they will provide a breakdown of shares sold at each price within the reported range upon request.
Insider Transaction Report
Form 4
KAO JOHN E
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-10$18.19/sh−180,000$3,273,552→ 2,472,641 total(indirect: See Footnote)
Holdings
- 1,568,379
Common Stock
Footnotes (3)
- [F1]Date of Rule 10b5-1 plan adoption: 03/12/2025
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.86 to $18.57. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao|2026-03-10